Both molecules might interact with transcription factors impinging on the Emx2 locus, ameliorating their binding to the chromatin and/or their processivity (like the Evf2-ncRNA at the Dlx5/6 locus) [25].
The invariance of these residues for all the sequences available during the 1970s thus could plausibly be attributed to their crucial role in binding to the heme via their distinctive side chains.
However, despite their clear therapeutic potential, relatively little is known regarding the molecular mechanisms underlying their binding to the CGRP receptor and their ability to antagonise CGRP action.
miRNAs are known to inhibit gene expression by binding to the 3' UTRs of their target transcripts [34].
Unlike natural sites, novel cryptic sites are not under selection to maintain binding to the spliceosome, and their genomic context is less constrained than natural splice sites.
These are short, non-coding RNA molecules that regulate gene expression post-transcriptionally, by binding to the 3′UTR of their target genes and limiting translation into protein.
In contrast, pCREB, CBP, p300, and PCAF all increased their binding to the TSHα promoter after cAMP treatment; however, their binding to the TSHα promoter was unaffected by T3.
TFs either directly regulate their targets by binding to the promoters or indirectly regulate their targets by the transcriptional regulatory chains through intermediate TFs [ 6, 7].
These results suggest that OsSMF1 directly regulates the expression of OsGZF1 and RPBF by binding to the ATGA motif in their promoters to regulate SSPs.
These results indicated that OsSMF1 regulated the expression of OsEnS44 and patatin-like genes by binding to the GCN4 motifs in their promoters.
